Short answer
Sensitivity measures how rarely a test misses real infections; specificity measures how rarely it cries wolf on healthy people.
Screening leans sensitive (catch everything, sort later); confirmation leans specific (verify before acting).
Neither number alone describes your result. Prevalence, timing, and collection quality complete the picture.
Understanding the pair converts confusing discordant results into predictable, manageable testing logic.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →Each concept in plain terms
- High sensitivity, missed little. A sensitive test rarely reports negative on infected people. Ideal first filters where missing cases costs most.
- High specificity, alarmed little. A specific test rarely reports positive on uninfected people. Ideal confirmers before treatment or disclosure.
- The inherent tension. Pushing one direction strains the other at the margins, which is why single-test strategies lose to staged strategies.
- Real-world modifiers. Window timing, sample quality, and site selection shift effective accuracy far more than catalog specifications.
Applied examples: False Positives and Negatives in STI Testing.
How clinics sequence the pair
Screening casts the sensitive net wide, then confirmation applies the specific test to catches only.
Syphilis runs this ladder explicitly (screening test, then different confirmatory test); HIV confirmation ladders similarly; low-prevalence herpes blood screening leans on confirmation hardest of all.
When your results follow this pattern, screen positive, confirm negative or vice versa, the system is working as designed, not malfunctioning.
What this means for your decisions
- Screening negatives reassure most when timing and sampling were right.
- Screening positives start confirmation, never treatment or disclosure.
- Confirmatory negatives after screening positives usually mean the screen erred. Follow the confirmation.
- Repeated discordance deserves clinician interpretation of your specific pattern, not internet generalities.
Applying the pair to real decisions
Real decisions use both metrics jointly, never singly: a sensitive screening positive in low-prevalence settings triggers specific confirmation before action; a specific confirmatory negative overrules the sensitive screen that preceded it; serial testing strategies sequence sensitive-then-specific deliberately.
Single-metric reasoning (trusting sensitivity alone, or dismissing screens for imperfect specificity) misreads designed systems as flawed ones.
Personalize with pre-test probability: your exposures, symptoms, and local prevalence set the prior that test characteristics modify.
High prior plus positive screen means near-certainty pending confirmation; low prior plus positive screen means coin-flip awaiting adjudication.
Same test, same result, opposite meanings across priors: Bayesian reasoning made practical, and the reason clinicians ask histories before interpreting paperwork.
When to seek care
Now if results and symptoms disagree, if a screening result surprised you, or if timing was early. Confirmatory workups and scheduled retests resolve what single results cannot.
Bring exposure dates and prior results to every follow-up.